Skip to main content
Have a personal or library account? Click to login
Management of cetuximab-induced skin toxicity with the prophylactic use of topical vitamin K1 cream Cover

Management of cetuximab-induced skin toxicity with the prophylactic use of topical vitamin K1 cream

Radiology and Oncology
Volume 44 (2010): Issue 4 (December 2010)
By:   
Open Access
|Sep 2010
References

References

  1. Segaert S, van Cutsem E. Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors.2005;1425-33.
    Open DOISearch in Google Scholar
  2. van Cutsem E, Kohne CH, Hitre E, Zaluski J, Chang Chien CR, Makhson A, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.2009;1408-17.
    Open DOISearch in Google Scholar
  3. Ocvirk J. Advances in the treatment of metastatic colorectal carcinoma.2009;1-8.
    Open DOISearch in Google Scholar
  4. Lacouture ME. Insights into the pathophysiology and management of dermatologic toxicities to EGFR-targeted therapies in colorectal cancer.2007;S17-26.
    Open DOISearch in Google Scholar
  5. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.2000;205-16.
    Open DOISearch in Google Scholar
  6. Erbitux. Summary of product characteristics. Available at
    Search in Google Scholar
  7. Ocvirk J, Rebersek M. Management of cutaneous side effects of cetuximab therapy with vitamin K1 cream.2008;215-24.
    Open DOISearch in Google Scholar
  8. . Edinburgh; October 2000. Available at
    Search in Google Scholar
  9. Tan EH, Chan A. Evidence-based treatment options for the management of skin toxicities associated with epidermal growth factor receptor inhibitors. Ann Pharmacother 2009;1658-66.
    Open DOISearch in Google Scholar
  10. Li TH, Perez-Soler R. Skin toxicities associated with epidermal growth factor receptor inhibitors.2009;107-19.
    Open DOISearch in Google Scholar
  11. Ocvirk J, Rebersek M. Treatment of cetuximab-associated cutaneous side effects using topical aplication oh vitamin K1 cream. [Abstract].2009;e15087.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10019-010-0036-6 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 265 - 266
Published on: Sep 22, 2010
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2010 Janja Ocvirk, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 44 (2010): Issue 4 (December 2010)
Previous article